9,10-dimethyl-1,2-benzanthracene has been researched along with estradiol 3-benzoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, M; Imai, T; Matsui, T; Mitsumori, K; Onodera, H; Takagi, H; Takizawa, T; Ueda, M; Yasuhara, K | 1 |
| Che, JH; Jang, DD; Kang, JS; Kim, DJ; Kim, S; Nam, KT; Yang, KH | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and estradiol 3-benzoate
| Article | Year |
|---|---|
Enhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Disease Progression; Estradiol; Female; Mammary Neoplasms, Animal; Methoxychlor; Ovary; Rats; Rats, Sprague-Dawley; Time Factors | 2002 |
Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkylating Agents; Animals; Carcinogens; Cell Differentiation; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley | 2004 |